Menu

Table of Contents:

Read online

Category

All
  • ASCO 2020
  • ASCO 2021
  • Clinical trials
  • Congress news
  • UPDATE adrenal cell carcinoma
  • UPDATE CRC

Tumortype

All
  • adrenal cell carcinoma
  • basal cell carcinoma
  • colorectal cancer
  • Gastro-intestinal cancer
  • Gastrointestinal cancer
  • Gynaecological cancer
  • kleincellige longkanker
  • longkanker
  • Lung cancer
  • melanoma
  • Skin cancer
  • small cell lung cancer

Year

All
  • 2020
  • 2021
  • 2022
SUBSCRIBE TO BJMO ONCOTALKS SERIES

Podcasts

June 2022

Dr. Wissam discusses the highlights on adjuvant therapy in cutaneous melanoma

Dr. Yacine Wissam, CHU de Charleroi, Charleroi, Belgium

In this podcast, Dr. Yacine Wissam will summarise the highlights on adjuvant therapy in cutaneous melanoma as presented by several speakers during the EADO 2022 congress.

“This podcast was brought to you by the publisher of the Belgian Journal of Medical Oncology (BJMO) in partnership with Novartis” 

March 2022

Prof. Sebahat Ocak discusses the 3-year overall survival data of the phase III, randomized controlled CASPIAN trial (French)

In this episode, Prof. Dr. Sebahat Ocak (CHU UCL Namur Site Godinne) discusses the most recent results of the phase III CASPIAN trial, evaluating the combination of platinum-etoposide and the immune checkpoint inhibitor durvalumab as first-line treatment for patients with extensive-stage small cell lung cancer.

This podcast episode was sponsored by AstraZeneca. Imfinzi® (durvalumab) is indicated as first-line treatment of ES-SCLC, in combination with etoposide and carboplatin or cisplatin. (NS ID XL-2634-Revision date 04/2022-WEB Local code 430). Click here for the SmPC

All podcasts

June 2022
Congress news 

Prof. Hoeller about the potential role for adjuvant therapy in the treatment of intermediate risk melanoma patients
Prof. Dr. Christopher Hoeller, Medical University of Vienna, Vienna, Austria
June 2022
Congress news 

Prof. Nikkels on the TELESPOT Project: a Belgian teledermoscopy system in primary healthcare centres for early detection of skin cancer
Prof. Dr. Arjen Nikkels, CHU de Liège, Liège, Belgium
March 2022

Prof. Annelies Janssens discusses the 3-year overall survival data of the phase III, randomized controlled CASPIAN trial (Dutch)
October 2021
Congress news 

Prof. Dr. Marc Van den Eynde about the results of the PRECONNECT study
Prof. dr. Marc Van den Eynde, digestive oncologist at the Clinique Universitaires Saint-Luc in Brussels
September 2021
Congress news 

Prof. Dr. Eric Van Cutsem about the highlights from ESMO World Congress on Gastrointestinal Cancer
August 2021
ASCO 2021 

Prof. dr. Eric Van Cutsem about the gastro-intestinal highlights from ASCO 2021
Prof. Eric Van Cutsem, head of the digestive oncology department, University Hospitals Leuven
X